Chemed Corp. (CHE) vs. The Joint Corp. (JYNT) Head to Head Comparison

Chemed Corp. (NYSE: CHE) and The Joint Corp. (NASDAQ:JYNT) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, profitability, dividends, analyst recommendations, earnings, institutional ownership and risk.

Dividends



Chemed Corp. pays an annual dividend of C$1.12 per share and has a dividend yield of 0.5%. The Joint Corp. does not pay a dividend. Chemed Corp. pays out 24.9% of its earnings in the form of a dividend. Chemed Corp. has raised its dividend for 8 consecutive years.

Volatility and Risk

Chemed Corp. has a beta of 1.14, meaning that its stock price is 14% more volatile than the S&P 500. Comparatively, The Joint Corp. has a beta of 1.43, meaning that its stock price is 43% more volatile than the S&P 500.

Earnings and Valuation

This table compares Chemed Corp. and The Joint Corp.’s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio NetIncome Earnings Per Share Price/Earnings Ratio
Chemed Corp. $1.58 billion 2.34 $108.74 million C$4.50 51.36
The Joint Corp. $20.52 million 3.54 -$15.17 million ($0.69) -7.99

Chemed Corp. has higher revenue and earnings than The Joint Corp.. The Joint Corp. is trading at a lower price-to-earnings ratio than Chemed Corp., indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of recent ratings and recommmendations for Chemed Corp. and The Joint Corp., as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Chemed Corp. 0 2 1 0 2.33
The Joint Corp. 0 0 4 0 3.00

Chemed Corp. currently has a consensus target price of C$228.50, suggesting a potential downside of 1.13%. The Joint Corp. has a consensus target price of $6.15, suggesting a potential upside of 11.62%. Given The Joint Corp.’s stronger consensus rating and higher probable upside, analysts plainly believe The Joint Corp. is more favorable than Chemed Corp..

Profitability

This table compares Chemed Corp. and The Joint Corp.’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Chemed Corp. 4.62% 27.69% 15.16%
The Joint Corp. -36.74% -94.08% -32.16%

Institutional & Insider Ownership

97.3% of Chemed Corp. shares are owned by institutional investors. Comparatively, 46.9% of The Joint Corp. shares are owned by institutional investors. 4.9% of Chemed Corp. shares are owned by insiders. Comparatively, 6.1% of The Joint Corp. shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

Chemed Corp. beats The Joint Corp. on 9 of the 16 factors compared between the two stocks.

About Chemed Corp.

Chemed Corporation purchases, operates and divests subsidiaries engaged in various business activities. The Company operates through two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company’s VITAS provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. VITAS is the provider of hospice services in an industry dominated primarily by small, non-profit, community-based hospices. VITAS provides hospice care to Medicare beneficiaries participating in these managed care programs. A portion of its VITAS business is operated in the state of Florida. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration and other related services to both residential and commercial customers.

About The Joint Corp.

The Joint Corp. develops, owns, operates, supports and manages chiropractic clinics through direct ownership, management arrangements, franchising and the sale of regional developer rights throughout the United States. The Company is franchisor and operator of chiropractic clinics. The Company offers its patients the opportunity to visit its clinics without an appointment and receive prompt attention. The Company has approximately 310 franchised, company-owned, or managed clinics in operation in over 30 states. In addition to its approximately 310 operating clinics, the Company has granted franchises either directly or through its regional developers for an additional over 170 clinics. The Company offers a range of membership and wellness packages. Each patient’s records are digitally updated for ready retrieval in its data storage system by its chiropractors in compliance with various applicable medical records security and privacy regulations.

Receive News & Ratings for Chemed Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed Corp. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply